Melatonin with chemotherapy for breast cancer before surgery
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests whether adding melatonin to standard chemotherapy before surgery can help treat breast cancer. The goal is to see if melatonin improves how well the chemotherapy works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with invasive breast cancer that hasn't spread to other parts of the body.
- Planning to receive chemotherapy before surgery (neoadjuvant chemotherapy).
- Fairly active and able to take care of yourself (ECOG performance status 0-2).
- Good kidney, liver, and bone marrow function (confirmed by blood tests).
- Not taking melatonin now or in the past month, and not allergic to it.
- Not pregnant or breastfeeding, and no autoimmune disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding radiation therapy to chemotherapy before surgery for people with locally advanced breast cancer that did not shrink enough with chemo alone. It may help improve outcomes for those with luminal (HER2-negative) or triple-negative types.
This trial studies treatments given before surgery for invasive breast cancer, aiming to shrink the tumor so surgery can be done more effectively. It may help some people need breast-conserving surgery or improve the chance of complete cancer removal.
This trial tests whether giving chemotherapy before surgery, guided by the genetic profile of your tumor, can improve outcomes for a specific type of HER2-positive breast cancer. It aims to tailor treatment to each person's cancer biology.
This trial tests a new combination of two chemotherapy drugs (Utidelone and Cisplatin) given before surgery for breast cancer. It is for people with early-stage breast cancer that has not spread to other parts of the body, and aims to shrink the tumor to make surgery more effective.
This Phase 3 trial compares hormone-based treatment versus chemotherapy given before surgery in people who are premenopausal and have hormone-receptor positive, HER2-negative breast cancer. It looks to see which approach works better to control the cancer before the breast operation.
This trial tests if taking melatonin or vitamin D can help protect the heart in women receiving doxorubicin chemotherapy for breast cancer. It aims to find a safe way to reduce heart damage from treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.